Table 4.
Clinical outcome of non-ICU-acquired pneumonia
| Variable | Overall (n = 379) | Treatment failure (n = 119) | Treatment success (n = 260) |
|---|---|---|---|
| Microbiologic responsec | |||
| Eradicationd | 56 (14.8) | 15 (35.7) | 41 (80.4)b |
| Colonizatione | 7 (1.8) | 0 | 7 (13.7)a |
| Failuref | 29 (7.7) | 26 (61.9) | 3 (5.9)b |
| Recurrenceg | 1 (2.6) | 1 (2.4) | 0 |
| Hospital length of stay, day | 29 (17–51) | 32 (18–63) | 28 (16–47) |
| Additional ICU admission associated with HAP | 107 (28.2) | 60 (50.4) | 47 (18.1)b |
| Survival discharge | 276 (72.8) | 25 (21.0) | 251 (96.5)b |
| Home discharge | 170 (44.9) | 6 (24.0) | 164 (65.3)b |
| Step down referral | 97 (25.6) | 16 (64.0) | 81 (32.3) |
| Step up referral | 9 (2.4) | 3 (12.0) | 6 (2.4) |
Values are presented as number (%) or median (interquartile range).
ICU, intensive care unit; HAP, hospital-acquired pneumonia.
a
p value was less than 0.05.
b
p value was less than 0.001.
c
Microbiologic response was revealed in only 93 of the study population (treatment failure 15; treatment success 41).
d
Absence of the baseline pathogen in the final culture of specimens during hospitalization.
e
Persistence of the baseline pathogen but clinically cured or f not clinically cured.
g
Regrowth of the baseline pathogen irrespective of clinical outcome.